# FDA again rejects Outlook's wet AMD drug; Chinese siRNA biotech expects $188M IPO

**Source:** Endpoints News
**URL:** https://e.endpointsnews.com/t/t-l-wntidl-jykykhhuld-k/
**Date:** 2026-01-02

---

December 29, 2025 12:42 PM ESTUpdated 3 hours ago News Briefing

FDA again reÂ­jects OutÂ­look's wet AMD drug; ChiÂ­nese siRÂ­NA biotech exÂ­pects $188M IPO

ENDPOINTS

Plus, news about InÂ­flaRx, ASK Pharm, UniÂ­cyÂ­cive, HarÂ­bour BioÂ­Med, Omeros, Gilead, ReÂ­pare TherÂ­aÂ­peuÂ­tics, VacÂ­cinex and ForeÂ­see PharÂ­maÂ­ceuÂ­tiÂ­cals.

ğŸ‘ï¸ FDA reÂ­jects OutÂ­look TherÂ­aÂ­peuÂ­ticsâ€™ verÂ­sion of â€¦

---

#news #endpoints-news
